Ars Pharmaceuticals Inc (SPRY)
$3.38 -7.65% Close Oct 30, 2026 Live
Ars Pharmaceuticals stock today
Ars Pharmaceuticals closed at $3.38 on October 30, 2026, down 7.65% on the day. Over the past year it returned -60.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $336 million.
$5.00$10.00
NovJan 2026MarMayJulSep
| Period | SPRY | S&P 500 (SPY) |
|---|---|---|
| 1 month | -21.6% | -0.9% |
| 3 months | -40.0% | +2.1% |
| Year to date | -71.0% | +11.7% |
| 1 year | -60.8% | +12.4% |
| 3 years | -2.9% | +88.5% |
| 5 years | -60.8% | +76.0% |
Key statistics
- Market value
- $336M
- Price / sales
- 2.9
- 52-week range
- $3.38 to $13.06
- Next report
- Nov 5, 2026
About Ars Pharmaceuticals
Develops pharmaceutical treatments for allergic and inflammatory conditions.
Sector: Health Care
More on Ars Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue -5% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $391.66 today
No forecast, no recommendation. This page describes Ars Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.